Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 19001205)

1.

Patient awareness of chronic kidney disease: trends and predictors.

Plantinga LC, Boulware LE, Coresh J, Stevens LA, Miller ER 3rd, Saran R, Messer KL, Levey AS, Powe NR.

Arch Intern Med. 2008 Nov 10;168(20):2268-75. doi: 10.1001/archinte.168.20.2268.

2.

Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction.

Tuot DS, Plantinga LC, Hsu CY, Jordan R, Burrows NR, Hedgeman E, Yee J, Saran R, Powe NR; Centers for Disease Control Chronic Kidney Disease Surveillance Team.

Clin J Am Soc Nephrol. 2011 Aug;6(8):1838-44. doi: 10.2215/CJN.00730111. Epub 2011 Jul 22.

3.

Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes?

Tuot DS, Plantinga LC, Hsu CY, Powe NR.

Am J Nephrol. 2012;35(2):191-7. doi: 10.1159/000335935. Epub 2012 Jan 27.

4.

Awareness of kidney disease in the US population: findings from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2000.

Nickolas TL, Frisch GD, Opotowsky AR, Arons R, Radhakrishnan J.

Am J Kidney Dis. 2004 Aug;44(2):185-97.

PMID:
15264176
5.

Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).

Whaley-Connell A, Sowers JR, McCullough PA, Roberts T, McFarlane SI, Chen SC, Li S, Wang C, Collins AJ, Bakris GL; KEEP Investigators.

Am J Kidney Dis. 2009 Apr;53(4 Suppl 4):S11-21. doi: 10.1053/j.ajkd.2009.01.004.

PMID:
19285607
6.

Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.

Ando M, Ohashi K, Akiyama H, Sakamaki H, Morito T, Tsuchiya K, Nitta K.

Nephrol Dial Transplant. 2010 Jan;25(1):278-82. doi: 10.1093/ndt/gfp485. Epub 2009 Sep 17.

7.
8.

Prevalence, awareness, treatment, and control of hypertension in elderly adults with chronic kidney disease: results from the survey of Prevalence, Awareness, and Treatment Rates in Chronic Kidney Disease Patients with Hypertension in China.

Cai G, Zheng Y, Sun X, Chen X; Survey of Prevalence, Awareness, and Treatment Rates in Chronic Kidney Disease Patients with Hypertension in China Collaborative Group.

J Am Geriatr Soc. 2013 Dec;61(12):2160-7.

PMID:
24479145
9.

Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).

Duru OK, Li S, Jurkovitz C, Bakris G, Brown W, Chen SC, Collins A, Klag M, McCullough PA, McGill J, Narva A, Pergola P, Singh A, Norris K.

Am J Kidney Dis. 2008 Feb;51(2):192-8. doi: 10.1053/j.ajkd.2007.09.023.

10.

Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000.

Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH.

J Am Soc Nephrol. 2005 Jan;16(1):180-8. Epub 2004 Nov 24.

11.

Hypertension awareness, treatment, and control in chronic kidney disease.

Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ, Bakris GL.

Am J Med. 2008 Apr;121(4):332-40. doi: 10.1016/j.amjmed.2007.11.025.

PMID:
18374693
12.

Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004.

Whaley-Connell AT, Sowers JR, McFarlane SI, Norris KC, Chen SC, Li S, Qiu Y, Wang C, Stevens LA, Vassalotti JA, Collins AJ; Kidney Early Evaluation Program Investigators.

Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S21-9. doi: 10.1053/j.ajkd.2007.12.013.

PMID:
18359404
13.

Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care.

Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre CW, Fluck RJ, Taal MW.

BMC Fam Pract. 2013 Jun 24;14:88. doi: 10.1186/1471-2296-14-88.

14.

Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.

Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, Levy D, Fox CS.

Am J Kidney Dis. 2008 Jul;52(1):39-48. doi: 10.1053/j.ajkd.2008.03.003. Epub 2008 Apr 28.

15.

Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.

Collins AJ, Vassalotti JA, Wang C, Li S, Gilbertson DT, Liu J, Foley RN, Chen SC, Arneson TJ.

Am J Kidney Dis. 2009 Mar;53(3 Suppl 3):S71-7. doi: 10.1053/j.ajkd.2008.07.057.

PMID:
19231764
17.

Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: a national online survey.

Agrawal V, Ghosh AK, Barnes MA, McCullough PA.

Am J Kidney Dis. 2008 Dec;52(6):1061-9. doi: 10.1053/j.ajkd.2008.06.022. Epub 2008 Oct 30.

PMID:
18976845
18.

Limited knowledge of chronic kidney disease and its main risk factors among Iranian community: an appeal for promoting national public health education programs.

Roomizadeh P, Taheri D, Abedini A, Mortazavi M, Larry M, Mehdikhani B, Mousavi SM, Hosseini FA, Parnia A, Nakhjavani M.

Int J Health Policy Manag. 2014 Apr 24;2(4):161-6. doi: 10.15171/ijhpm.2014.37. eCollection 2014 May.

19.

Cross-sectional and case-control analyses of the association of kidney function staging with adverse postoperative outcomes in general and vascular surgery.

Gaber AO, Moore LW, Aloia TA, Suki WN, Jones SL, Graviss EA, Knight RJ, Bass BL.

Ann Surg. 2013 Jul;258(1):169-77. doi: 10.1097/SLA.0b013e318288e18e.

PMID:
23478526
20.

Risk factors for progression in patients with early-stage chronic kidney disease in the Japanese population.

Yoshida T, Takei T, Shirota S, Tsukada M, Sugiura H, Itabashi M, Ogawa T, Uchida K, Tsuchiya K, Nitta K.

Intern Med. 2008;47(21):1859-64. Epub 2008 Nov 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk